Redhawk Wealth Advisors Inc. Has $973,000 Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Redhawk Wealth Advisors Inc. raised its stake in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 12.0% during the fourth quarter, Holdings Channel reports. The firm owned 7,762 shares of the company’s stock after buying an additional 834 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in Addus HomeCare were worth $973,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Addus HomeCare during the 3rd quarter worth approximately $1,622,000. Dimensional Fund Advisors LP increased its holdings in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares in the last quarter. Point72 Asset Management L.P. raised its stake in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Addus HomeCare by 10.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after acquiring an additional 16,997 shares in the last quarter. Finally, American Century Companies Inc. boosted its holdings in shares of Addus HomeCare by 90.6% in the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after acquiring an additional 8,743 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Up 2.1 %

Shares of ADUS stock opened at $131.27 on Thursday. The firm has a market capitalization of $2.38 billion, a price-to-earnings ratio of 30.04, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. Addus HomeCare Co. has a 12-month low of $85.94 and a 12-month high of $136.12. The firm has a fifty day moving average of $125.07 and a 200-day moving average of $126.29.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the previous year, the firm earned $1.03 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. Research analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. JMP Securities started coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective for the company. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Macquarie reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer raised their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $133.67.

Check Out Our Latest Report on ADUS

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,750 shares of company stock worth $4,930,750. Company insiders own 4.60% of the company’s stock.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.